Drug Search Results
More Filters [+]

Vinpocetine

Alternative Names: vinpocetine, vinpocetin
Latest Update: 2024-07-09
Latest Update Note: News Article

Product Description

Mechanisms of Action: PDE Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Bangladesh | Bosnia | Bulgaria | China | Czech | Dominican Republic | Ecuador | Egypt | Hungary | India | Latvia | Lithuania | Mexico | Pakistan | Peru | Poland | Portugal | Romania | Russia | Serbia | Singapore | Slovakia | Slovenia | Spain | Ukraine | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Amen Clinics
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Vinpocetine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Diabetic Nephropathy|Kidney Diseases|Inflammation|Stroke

Phase 2: Epilepsy

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT06441591

P3

Recruiting

Kidney Diseases|Diabetic Nephropathy

2025-06-01

IRB00044949

P2

Suspended

Epilepsy

2024-08-01

ChiCTR-IOR-14005688

N/A

Not yet recruiting

Unknown

2018-12-31

TianjinMUGH1

P3

Completed

Inflammation|Stroke

2015-12-01

Recent News Events